Eli Lilly warns some Medicare plans may exceed the $50 monthly cap for weight‑loss drugs under a new CMS model.
But the FDA’s decision does not preclude CMS from determining that the higher dose is not reasonable and necessary — ...
Revisions to the US Centers for Medicare & Medicaid Services’ (CMS) competitive bidding programme (CBP) have been welcomed by the medtech industry, despite remaining concerns. The CMS has outlined ...
Leading Republicans are looking toward the Government Accountability Office (GAO) to ensure CMS' new premium stabilization demonstration program is legal and in the best interest of seniors. In a ...
Drug-related provisions of a landmark Biden-era law were tied to a decline in cost-related medication nonadherence among ...
As discussed in last week’s Regs & Eggs blog post, the US Department of Health and Human Services (HHS) recently released additional budget documents to support the department’s fiscal year (FY) 2026 ...
The Centers for Medicare & Medicaid Services announced a seven-prong update to the Civil Money Penalty Reinvestment Program on Monday. The agency has increased the project funding cap by 20% and also ...
The U.S. Centers for Medicare and Medicaid Services alleges the Indianapolis-based health insurer has failed to properly submit required information to federal regulators since 2018.
The Medicare Diabetes Prevention Program (MDPP) is a milestone of innovation. First, it was the first Center for Medicare and Medicaid Innovation (CMMI) model test to be expanded as a standard benefit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results